Clinical Trials Logo
  1. Home
  2. Qt Interval, Variation in
  3. NCT04000542

Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications

Qt Interval, Variation in Clinical Trial

Official title:
Community Pharmacist Use of Mobile ECG to Inform Drug Therapy Decision Making for Patients Receiving QT Prolonging Medications

Clinical Trial Summary

Torsade de pointes (TdP) is a cardiac arrhythmia associated with QT interval prolongation which may lead to cardiac arrest. Prescription medications which cause QT interval prolongation are commonly used in daily practice. To lessen risk of TdP, pharmacists work to minimize combinations of QT interval prolonging drugs. If community pharmacists had real-time information about a patient's QT interval duration, this would have the direct ability to inform their decision making about which patients may be at highest risk of TdP and who may need heightened avoidance of QT prolonging drugs. This project will provide 3 community pharmacies with mobile ECG devices to easily determine QT intervals among patients who have a prescription profile alert for QT interval prolongation. Study outcomes will include: frequency of QT interval prolongation, changes in drug therapy related to QT interval determination, and patient and pharmacist satisfaction with having pharmacist assessment of QT interval.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04000542
Study type Interventional
Source Northeast Iowa Medical Education Foundation
Contact
Status Completed
Phase N/A
Start date July 11, 2019
Completion date March 31, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT04966325 - Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects Early Phase 1
Completed NCT02924337 - Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects Phase 1
Completed NCT02241252 - Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients N/A
Completed NCT02063620 - The Effect of Anesthetic Agents Management on ECG Changes of Patients Who Were Operated Under RIVA N/A
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT05757063 - Impact of Two Different Types of Sedation on ICEB N/A
Completed NCT03822520 - Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib Phase 1
Not yet recruiting NCT04437901 - COVIDAR - Arrhythmias in COVID-19
Suspended NCT04005027 - Exercise Induced QT Interval Changes in Response to Intermittent and Continuous Graded Exercise Tests N/A
Recruiting NCT05488470 - QT Changes as Detected From LINQ ECG During and After Antiarrhythmic Loading (LINQ QT)
Completed NCT02492347 - Effect of Antenatal SSRI Exposure on the QT Interval of Neonates N/A
Completed NCT02217930 - Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers Phase 1
Completed NCT01365806 - Home Electrocardiogram (ECG) Monitoring After Heart Transplantation N/A
Active, not recruiting NCT03642405 - Drug-induced Repolarization ECG Changes
Completed NCT03475459 - Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7) Phase 1